Publications by authors named "Seemal Desai"

Claim this Profile
M
Maximizing a Focused Vitiligo Patient Visit: A Practical Approach.
Abrar Qureshi, Hira Ghani, Seemal Desai, Andrew Alexis, Pearl Grimes

J Drugs Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation.
Seemal R Desai, Edward Ted Lain, Nada Elbuluk, Cheri Frey

J Drugs Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global consensus on the management of melanin hyperpigmentation disorders.
Thierry Passeron, Seemal R Desai, Marwa Abdallah, Firas Al-Niaimi, Ncoza Dlova

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paving the Way to Healthcare Equity: A Comprehensive Review of Care Gaps and Emerging Initiatives in Dermatology.
Andrew Alexis, Raj Chovatiya, Susan Taylor, Nada Elbuluk, Chesahna Kindred, Seemal R Desai

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication.
David Rosmarin, Thierry Passeron, Amit G Pandya, Pearl Grimes, John E Harris, Seemal R Desai

Ther Adv Chronic Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consumer Risk in Henna Use: Labeling, Ingredients, and Allergen Disclosure.
Iman Bouchelkia, Zaryab Alam, Aarthi Annamalai, Kritin K Verma, Michelle B Tarbox, Seemal R Desai

Int J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Risks of Psychiatric Comorbidities in Melasma Patients Treated With Tranexamic Acid: A Multicenter Cohort Study.
Kritin K Verma, Kevin T Nguyen, Sabrina C Camacho, Sahil Kapur, Kermanjot Sidhu, Seemal R Desai

Int J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a 2-MNG-Containing Serum and Sunscreen Regimen on Improving Facial Dyschromia in Women with Skin of Color.
Hawasatu Dumbuya, Andrew Alexis, Stephen Lynch, Valerie Callender, Seemal R Desai

J Clin Aesthet Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of an educational intervention to introduce adolescents from marginalized backgrounds to dermatology: A pilot initiative.
Heli Patel, Hrushikesh Patel, Ross O'Hagan, Robert Smith, Adam Friedman, Seemal R Desai

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.
Amy McMichael, Mona Shahriari, Linda Stein Gold, Theodore Alkousakis, Olivia Choi, Seemal R Desai

JAMA Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.
Andrew Alexis, Amy McMichael, Jennifer Soung, Olivia Choi, Theodore Alkousakis, Seemal R Desai

JAMA Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Fitzpatrick skin types: A Delphi consensus on key considerations for a universal skin typing classification.
Valerie D Callender, Andrew Alexis, Seemal R Desai, Tarannum Jaleel, Henry W Lim

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delphi consensus on melasma management by international experts and pigmentary disorders society.
Rashmi Sarkar, Seemal R Desai, Surabhi Sinha, Sunil Dogra, María-Ivonne Arellano-Mendoza

J Eur Acad Dermatol Venereol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification system.
Valerie M Harvey, Stafford G Brown, Cheryl M Burgess, Angel S Byrd, Caryn B C Cobb, Seemal R Desai

J Am Acad Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating AI-Generated Responses for Patient Counseling and Treatment Decision-Making in Melasma: A Cross-Sectional Study.
Shreya Deoghare, Rashmi Sarkar, Seemal R Desai

Cureus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The American Academy of Dermatology and International League of Dermatological Societies' Drug Resistant Dermatophytes (Tinea) Registry: The latest addition to the COVID-19, mpox, and Emerging Infections Registry.
Ditte M L Saunte, Sidra Khan, Morvarid Zehtab, Avrom S Caplan, Jeremy A W Gold, Seemal R Desai

JAAD Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation.
Cheri Frey, Pearl Grimes, Valerie D Callender, Andrew Alexis, Hilary Baldwin, Seemal R Desai

J Drugs Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies.
Julien Seneschal, Albert Wolkerstorfer, Seemal R Desai, Pearl Grimes, Khaled Ezzedine

Dermatol Ther (Heidelb)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking the use of population descriptors in dermatology trials and beyond: disentangling race and ethnicity from skin color.
Valerie M Harvey, Jenna C Lester, Tarannum Jaleel, Junko Takeshita, Amy J McMichael, Seemal R Desai

Arch Dermatol Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement.
Andrew Alexis, Amy McMichael, Neelam Vashi, Tina Bhutani, Adrian O Rodriguez, Seemal R Desai

JAMA Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging cultural practices and skin cancer screening: the role of henna artists in acral melanoma detection.
Kritin K Verma, Michelle B Tarbox, Daniel P Friedmann, Seemal R Desai, Neal Bhatia

Arch Dermatol Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation.
Iltefat H Hamzavi, Anand K Ganesan, Bassel H Mahmoud, Eduardo Weiss, Ammar M Ahmed, Alpesh Desai, Seemal Desai

J Am Acad Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry.
Jonathan I Silverberg, Linda Stein Gold, Seemal Desai, Alexandra Golant, Douglas DiRuggiero

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Vitiligo Literature to Standardize Expression of Disease Severity.
Yael Renert-Yuval, Seemal Desai, Victor Huang, Samantha Walsh, David Rosmarin

J Drugs Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel.
Joshua Burshtein, Danny Zakria, Milaan Shah, Brian Berman, Seemal R Desai

J Drugs Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis